Main Article Content


Background: Systemic Lupus Erythematosus (SLE) is an autoimmune disease with wide range of clinical symptoms. The patients frequently complain musculoskeletal involvement during the active state of the disease. Musculoskeletal manifestation in SLE patients is an important sign in making early diagnosis and monitoring treatment response. This study aims to determine the presentation of musculoskeletal involvement of SLE patients in Dr. Hasan Sadikin General Hospital Bandung.

Methods: a descriptive cross-sectional quantitative study done by interviewing SLE patients concerning musculoskeletal manifestation as the primary data and tracking their medical record as the secondary data. Study was conducted between September to November 2016 in Rheumatology Clinic Dr. Hasan Sadikin General Hospital Bandung.

Result: Ninety-seven SLE patients, 91 females (93,81%) and 6 males (6,19%), were enrolled in this study with mean age 35.12 (±10.91) years. The three highest proportions of muskuloskeltal manifestations were arthritis of the knee (84,5%), myalgia of upper back
(40,2%), and muscle weakness (15,5%). We did not find any Jaccoud’s Arthropathy (JA) and tendinitis manifestation. Osteoporosis were occured in 4 patients (4,12%), whereas gout arthritis, spondytlitis, osteoarthritis, rotator cuff syndrome, and rhupus were
only occured in one patient (1,03%), respectively.

Conclusion: The common musculoskeletal manifestation in SLE patients were arthritis of knee, myalgia of upper back, and muscle weakness. Only small portion of patients suffered from osteoporosis, gout arthritis, spondytlitis, osteoarthritis, rotator cuff syndrome, and rhupus.

Keyword: musculoskeletal manifestation, musculoskletal involment, SLE

Article Details

How to Cite
Sutrisno, R. N., Rahmadi, A. R., Novita, N., & Hamijoyo, L. (2017). Most Frequent Musculoskeletal Manifestation of Systemic Lupus Erythematosus Patients in Dr. Hasan Sadikin General Hospital Bandung. Indonesian Journal of Rheumatology, 9(2).


  1. Bertsias G, Cervera R, Boumpras D. Systemic lupus erythematosus: pathogenesis and clinical features. Eular On-line Course Rheum Dis. 2012;(1909):476–505.
  2. Somers E, Marder W, Cagnoli P, Lewis E, DeGuire P, Gordon C, et al. Population-based incidence and prevalence of systemic lupus erythematosus. Arthritis Rheumatol. 2014;66(2):369-378
  3. Kasjmir Y, Handono K, Wijaya LK, Hamijoyo L, Albar Z, Kalim H, et al. Rekomendasi perhimpunan reumatologi Indonesia untuk diagnosis dan pengelolaan lupus eritematosus sistemik. 2011: 1-54 .
  4. Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P, et al. Morbidity and mortality in systemic lupus erythematosus during a 10- Year period a comparison of early and late manifestations in a cohort of 1.000 patients. Mortality. 2003;82(5): 299–308
  5. Navara SV, Torralba TP. The musculoskeletal system and bone metabolism. In : Dubois’ lupus erythematosus and related syndromes, 8th ed. Wallace Daniel J, Hanh Bevra H, editors. Philadelphia: Elsevier Saunders;2013: 333-40
  6. Beckerman N, Auerbach C, Blanco Irene. Psychosocial dimension of SLE: implication for the health team. J Multidiscip Healthc. 2011;4:63-72
  7. Backman C. Arthritis and pain, psychosocial aspect in the management of arthritis pain. Arthritis Res Ther. 2006;8(6):221.
  8. Ghaleb RM, Omar GM, Ibrahim MA. Avascular necrosis of bone in systemic lupus erythematosus. Egypt Rheumatol. 2011;33(1):27–33.
  9. Ball EMA, Bell AL. Lupus arthritis-do we have a clinically useful classification?. Rheumatology. 2012;51(5):771–9.
  10. Lam NVU, Ghetu M V, Bieniek ML, Luke S. Systemic lupus erythematosus: primary care approach to diagnosis and management. Am Fam Physician. 2016;94(4):284–94.
  11. Simard JF, Sjöwall C, Rönnblom L, Jönsen A. Systemic lupus erythematosus prevalence in Sweden in 2010 : what do national registers say ? Arthritis Care Res. 2014;66(11):1710–17.
  12. Feldman CH, Hiraki LT, Liu J, Fischer MA, Solomon DH, Winkelmayer WC, et al. Epidemiology and sociodemographics of systemic lupus erythematosus and Lupus nephritis among US adults with medicaid coverage. Arthritis and Rheumatism. 2013;65(3):753–63.
  13. Lourenço E V, Liu A, Matarese G, La A. Leptin promotes systemic lupus erythematosus by increasing autoantibody production and inhibiting immune regulation. Proc Natl Acad Sci USA. 2016; 113(38):10:637-42.
  14. Wahrenberg H, Hruska K, Reynisdottir S, Arner P, Hellstro L. Mechanisms behind gender differences in circulating leptin levels. J Intern Med. 2000;247(4):457–62.
  15. Pierdominici M, Ortona E. Estrogen impact on autoimmunity onset and progression : the paradigm of systemic lupus Erythematosus. Int Trend Immun. 2013;1(2):24–34.
  16. Perl A, Francis L. Infection in systemic lupus erythematosus: friend or foe. Int J Clin Rheumatol. 2010;5(1):59-74
  17. Smith PP, Gordon C. Autoimmunity reviews systemic lupus erythematosus : clinical presentations. Autoimmun Rev. 2010;10(1):43–5.
  18. Hospital C, Sciences B. Manifestations of Systemic Lupus Erythematosus. Maedica. 2011;6(4):330-36.
  19. Ball EMA, Gibson DS, Bell AL. Plasma IL-6 levels correlate with clinical and ultrasound measures of arthritis in patients with systemic lupus erythematosus. Lupus. 2014;23(1):46-56.
  20. Zoma A. Musculoskeletal involvement in systemic lupus erythematosus. Lupus. 2004;13(11):851–3.
  21. Record JL, Beukelman T, Cron RQ. High prevalence of myositis in a southeastern United States pediatric systemic lupus erythematosus cohort. Pediatr Rheumatol Online J. 2011;9:201–6.
  22. Font J, Cervera R, Ramos-casals M, Garcı M, Herrero C, Olmo J, et al. Clusters of clinical and immunologic features in systemic lupus erythematosus: analysis of 600 patients from a single center. Semin Athritis Rheum. 2004;33(4):217–30.
  23. Skare TL, Godoi Ade L, Ferreria Vo. Jaccoud arthropathy in systemic lupus erythematosus:clinical and serological findings. Rev Assoc Med Bras 2012; 58 (4): 489-92.
  24. Ogura T, Hirata A, Hayashi N, Takenaka S, Ito H, Mizushina K, et al. Comparison of ultrasonographic joint and tendon findings in hands between early, treatment-naive patients with systemic lupus erythematosus and rheumatoid arthritis. Sage J. 2016;1–8.
  25. García-carrasco M, Mendoza-pinto C, Escárcega RO, Jiménez-hernández M, Etchegaray I, Pt M, et al. Osteoporosis in patients with systemic lupus erythematosus. Isr Med Assoc J .2009;11(8):486–91.
  26. Tarhan F, Argın M, Can G, Özmen M, Keser G. Coexistence of systemic lupus erythematosus and ankylosing spondylitis : another case report and review of the literature. Eur J Rheumatol. 2014;1(1):39–43.
  27. Tani C, Aniello DD, Sedie AD, Carli L, Cagnoni M, Possemato N, et al. Autoimmunity Reviews Rhupus syndrome : Assessment of its prevalence and its clinical and instrumental characteristics in a prospective cohort of 103 SLE patients. Autoimmun Rev. 2013;12(4):537-41.